Zai Lab Limited Share Price OTC Markets
Stocks
ZAIL.F
KYG9887T1168
Pharmaceuticals
OTC Markets Traded
| Market Cap | 1.98B 1.72B 1.59B 1.49B 2.78B 190B 2.83B 18.91B 7.32B 91.48B 7.44B 7.28B 318B | P/E Ratio 2026 * |
-7.97x | P/E Ratio 2027 * | -9.46x |
|---|---|---|---|---|---|
| Enterprise Value | 1.54B 1.34B 1.23B 1.15B 2.15B 147B 2.2B 14.68B 5.68B 71.02B 5.78B 5.65B 247B | EV / Sales 2026 * |
3.43x | EV / Sales 2027 * | 2.68x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 60 | 31/03/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 06/07/2023 |
Rafael Amado
PSD | President | 62 | 30/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 60 | 31/03/2014 |
John Diekman
BRD | Director/Board Member | 82 | 31/12/2016 |
Peter Wirth
BRD | Director/Board Member | 74 | 31/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.98B | |
| +1.63% | -2.74% | +17.91% | -18.09% | 62.21B | |
| +1.03% | +4.90% | +67.41% | +222.19% | 59.45B | |
| -0.92% | +28.60% | +28.60% | +28.60% | 38.9B | |
| +0.26% | +9.80% | -55.40% | -65.15% | 36.4B | |
| +2.94% | +1.79% | +50.28% | -35.26% | 29.52B | |
| +2.32% | +6.51% | +56.62% | +76.65% | 21.54B | |
| +7.94% | -3.78% | +78.88% | -59.73% | 19.7B | |
| +4.80% | -0.20% | -5.33% | +112.95% | 16.18B | |
| -0.94% | -2.55% | +48.43% | +99.63% | 15.89B | |
| Average | +1.90% | +1.46% | +31.93% | +40.20% | 33.31B | |
| Weighted average by Cap. | +1.63% | +1.87% | +30.55% | +45.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 449M 389M 359M 336M 628M 42.96B 641M 4.28B 1.66B 20.71B 1.68B 1.65B 72.01B | 596M 517M 476M 446M 834M 57.03B 851M 5.68B 2.2B 27.49B 2.24B 2.19B 95.58B |
| Net income | -241M -209M -193M -181M -337M -23.07B -344M -2.3B -890M -11.12B -904M -885M -38.66B | -156M -136M -125M -117M -219M -14.98B -224M -1.49B -578M -7.22B -587M -575M -25.11B |
| Net Debt | -443M -385M -354M -332M -621M -42.43B -633M -4.23B -1.64B -20.45B -1.66B -1.63B -71.11B | -387M -336M -310M -290M -542M -37.07B -554M -3.69B -1.43B -17.87B -1.45B -1.42B -62.14B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
